Related Experiment Videos
Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans
M Kupari1, M Perola, P Koskinen
1First Department of Medicine, Helsinki University Central Hospital, Finland.
The American Journal of Physiology
|September 1, 1994
Summary
The angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism does not significantly impact left ventricular (LV) mass or function in healthy individuals. Echocardiography revealed no detectable differences across II, ID, and DD genotypes in subjects without heart disease.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
Background:
- The angiotensin-converting enzyme (ACE) gene possesses a common insertion/deletion (I/D) polymorphism.
- The DD genotype is associated with higher ACE activity and linked to left ventricular (LV) hypertrophy and dysfunction in disease states.
Purpose of the Study:
- To investigate whether the ACE gene I/D polymorphism influences LV mass or function in individuals without diagnosed heart disease.
- To determine if genetic variation in ACE predicts subclinical cardiac structure and function.
Main Methods:
- Genotyping for the ACE I/D polymorphism was performed using polymerase chain reaction on leukocyte DNA.
- Left ventricular (LV) mass and function were assessed using M-mode and Doppler echocardiography.
- Study population comprised 86 healthy adults aged 36-37 years.
Main Results:
- No significant differences in LV mass-to-body height ratio were observed among the II (99 ± 19 g/m), ID (99 ± 30 g/m), and DD (94 ± 24 g/m) genotype groups (P = 0.790).
- Echocardiographic indices of both systolic and diastolic LV function were not found to be related to ACE genotype.
- These findings indicate no detectable influence of ACE gene variation on LV structure or function in the absence of heart disease.
Conclusions:
- In healthy individuals, the ACE gene I/D polymorphism does not appear to exert a major influence on left ventricular mass or function detectable by echocardiography.
- The genetic variation in ACE may not be a significant determinant of subclinical cardiac phenotype in the absence of cardiovascular pathology.